Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05023096 · ClinicalTrials.gov registry record · NA
Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT05023096: Completed NA study, sponsored by Virginia Commonwealth University.
NCT05023096 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05023096, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study aims to better understand how the availability of electronic nicotine delivery system (aka electronic cigarettes) flavors (e.g., menthol, tobacco) impacts tobacco use behaviors, toxicant exposure, and abuse liability among African American menthol smokers.
Primary Outcome
Number of cigarettes used in the past day, collected via daily text survey, averaged over the past week
Interventions
- OTHER Tobacco product administration and assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2022-04-14 |
| Est. Completion | 2024-10-15 |
| Phase | NA |
What the finished NCT05023096 record still lists
NCT05023096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Tobacco product administration and assessment is the first listed.
NCT05023096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05023096 about?
NCT05023096 is a clinical study titled "Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers". This study aims to better understand how the availability of electronic nicotine delivery system (aka electronic cigarettes) flavors (e.g., menthol, tobacco) impacts tobacco use behaviors, toxicant exposure, and abuse liability among African American menthol smokers.
What is the current status of trial NCT05023096?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2022-04-14. Estimated completion is 2024-10-15.
What interventions are being tested in trial NCT05023096?
The interventions under investigation include: Tobacco product administration and assessment (OTHER).
Who is sponsoring clinical trial NCT05023096?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05023096's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI